With its stunning Frank Lloyd Wright design, the Guggenheim Museum is a piece of art in itself. Inside these rounded walls, ...

Michael Morris, Guggenheim Securities analyst, joins 'Squawk on the Street' to discuss what's at stake for Netflix, some of ...

Vamil Divan, Guggenheim Securities analyst, joins 'Squawk on the Street' to discuss Pfizer's guidance, how optimistic Divan ...

Neogen Corp (NEOG) stock saw a modest uptick, ending the day at $12.43 which represents a slight increase of $0.21 or 1.72% from the prior close of $12.22. The stock opened at $12.01 and touched a low ...

First Stamford Place is the new home of Guggenheim Partners' Connecticut office. Photo courtesy of Newmark Group STAMFORD – The ...

The Guggenheim's Orphism exhibition includes more than 90 artworks on display in its iconic rotunda, celebrating the 1910s ...

As previously reported, Guggenheim initiated coverage of Neogen (NEOG) with a Buy rating and $15 price target Neogen is a ...

This is what sign language poetry, a genre rooted in the sign language tradition, looks like: a feast for the eyes.

NEW YORK, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Guggenheim Investments today announced that certain closed-end funds have declared their distributions. The table below summarizes the distribution ...

Credit: Pentagram/Guggenheim Since its conception in 1939, the Guggenheim Museum has grown to become a global cultural brand, evolving with an increasing need for a strong unified visual identity.

Guggenheim lowered the firm’s price target on Pfizer (PFE) to $33 from $35 and keeps a Buy rating on the shares. Pfizer will be releasing their ...

Guggenheim lowered the firm’s price target on AnaptysBio (ANAB) to $36 from $90 and keeps a Buy rating on the shares following the announcement ...